JOST Werke AG (JST)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 59.60 |
|---|---|
| 52-week range | 48.30 – 67.80 |
| Return, 1 month / 3 months | −3.7% / +7.0% |
| Return, 1 year / 3 years | +17.0% / +44.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -26.5% |
| Average daily value traded | 1.36M EUR |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
JOST Werke AG is a German manufacturer of components for commercial vehicles, trailers and agricultural machinery. Its products include fifth wheels, kingpins, landing gear and other parts that connect and support trucks and trailers, along with front loaders and attachments for tractors and forestry equipment. The company supplies vehicle makers and fleet operators, and its parts are used in transport and farming applications. JOST Werke is based in Neu-Isenburg, Germany, and serves customers in many countries.
The shares are listed on the XETRA Stock Exchange in Germany under the code JST, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
JOST Werke AG (JST) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 59.60 on 23 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 163 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.0% and over the last three months it rose 7.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.9% | ||
| From 52-week high | -11.4% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.0% | ||
| 6-month return | 13.3% | ||
| 12-month return, skipping the last month | 21.5% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.5% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 1.36M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −3.7% |
| 3 months | +7.0% |
| 6 months | +13.3% |
| 1 year | +17.0% |
| 3 years | +44.8% |
| 5 years | +36.6% |
Signals
| 50-day / 200-day average | 60.76 / 57.39 |
|---|---|
| Golden / death cross (60 days) | Golden, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | EUR 1.5000 |
| 9 May 2025 | EUR 1.5000 |
| 9 May 2024 | EUR 1.5000 |
| 12 May 2023 | EUR 1.4000 |
| 6 May 2022 | EUR 1.0500 |
| 7 May 2021 | EUR 0.8706 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.